February 16, 2017 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought AstraZeneca PLC, a stock transaction, valued at $1,000 - $15,000. The trade took place on February 16, 2017 and was disclosed on March 2, 2017 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.